Condition-specific coaching and care AI
Lucia Health Coach
This profile covers Lucie on the Heart Rhythm Society’s UpBeat website, supported by BMS-Pfizer. It offers AFib education. Sponsorship is disclosed, but response sourcing, redirection, privacy behavior, and actual sponsor influence were not tested.
Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.
Agency checklist · October 30, 2026
Mixed 5 of 12 yes
Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.
Assessed function: Lucie, Lucia Health Guidelines' generative AI chatbot on the Heart Rhythm Society's UpBeat.org AFib education site. Other Lucia provider workflows are outside this assessment.
Astra review conflicted: OpenAI model in role record.
A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.
- Public documents do not establish actual product behavior.
- The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
| Question | Answer | Evidence / review | Source and reasoning |
|---|---|---|---|
| 1. Told it is AI | Yes | documented Not independently replicated | Our sites may use a generative AI Chatbot to provide general information and support.Source HRS privacy policy. The Lucie terms page is titled 'HRS Terms and Conditions for AFib Chatbot (Lucie)' and says Lucie is not a licensed medical professional. |
| 2. Operator and model maker named | Yes | documented Not independently replicated | Empathetic, GPT.4-Powered, RAG- Trained CompanionSource Operator: the Terms page says 'Lucie represents a strategic collaboration between Lucia Health Guidelines and the Heart Rhythm Society'. The page names the model as GPT-4 but does not literally name OpenAI. Vendor marketing page, so reviewer should confirm the UpBeat deployment uses GPT-4. |
| 3. Patient chooses to use it | Yes | documented Not independently replicated | To allow you to participate in any interactive features on our Services, including interacting with a ChatbotSource A public-website feature that a visitor chooses to use. No clinician or institution applies it. |
| 4. Patient sets the task | No | not-documented Not independently replicated | Sponsored by the BMS-Pfizer AllianceSource Nothing says the visitor sets the purpose. The pilot was sponsored by the BMS-Pfizer Alliance and content is HRS-curated AFib education. A visitor does choose the questions. |
| 5. Patient can decline or stop | Yes | documented Not independently replicated | To allow you to participate in any interactive features on our Services, including interacting with a ChatbotSource Rule applied: Q3 is yes and no care or service depends on the chatbot (an optional education feature), so Q5 is yes, citing the Q3 source. |
| 6. Patient sees the AI output | Yes | documented Not independently replicated | The content provided by Lucie is intended strictly for general informational purposesSource The visitor reads Lucie's replies in the chat. |
| 7. Patient can correct or challenge | No | not-documented Not independently replicated | We want your feedback! Visit the Contact Us page to submit suggestions, questions, or overall impressions of your experience with Lucie.Source A general feedback channel exists, but no route to correct or contest a specific output is documented. |
| 8. Patient can get a copy | No | documented Not independently replicated | Data Portability. You may have the right to request a copy of your personal informationSource Rights are residency-dependent ('Depending on your state or country of residency, you may have certain privacy rights'). The policy asks visitors not to share personal or protected health information with a Chatbot. |
| 9. Patient can delete | No | documented Not independently replicated | Right to Deletion. You may have the right to request that we delete personal information that we have collected from you.Source Same residency-dependent caveat as Q8. |
| 10. Training or sale does not override patient choice | No | documented Not independently replicated | We may retain transcripts of chats to analyze usage, improve a Chatbot’s performance, and monitor engagement.Source 'By using a Chatbot, you agree to these practices.' No opt-out other than not using it, apart from residency-dependent rights such as limiting use of sensitive data. |
| 11. Patient can run it or take it elsewhere | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source Vendor-hosted. No patient route to run it or move the function. |
| 12. No advertising or data business | No | documented Not independently replicated | We may share aggregate, de-identified information about how a Chatbot is used for research purposes or with a Chatbot’s funder.Source The funder of the pilot was the BMS-Pfizer Alliance (Lucia press release). The policy also says HRS does not engage in targeted advertising or sale. |
Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.
Checklist rules · Independent review and limitations · Later evidence follow-up
Earlier v1.3 assessment and control finding
Historical assessment under different rules. It does not set the current checklist zone.
Agency finding, before method v1.3
Potentially agency-expanding
Legacy editorial placement, pre-method: 62
This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.
- Evidence
- Documentary review. Public sources only, no hands-on testing by HugoScore.
- Review status
- AI draft. No person has settled the findings.
Earlier evidence and assessment
The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.
Earlier finding · Legacy editorial placement, pre-method: 62
Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 62. Not comparable with v1.3 positions.
Potentially agency-expanding
This profile covers Lucie on the Heart Rhythm Society’s UpBeat website, supported by BMS-Pfizer. It offers AFib education. Sponsorship is disclosed, but response sourcing, redirection, privacy behavior, and actual sponsor influence were not tested.
Patient agency
How this tool changes agency
Condition education can prepare discussion, but actual response provenance, alternative explanations and correction behavior are not established from terms.
Answer sourcing, user redirection, retention and sponsor influence in conversation remain unverified
Patient agency assessment
Who sets and changes the goal?
The public educational deployment offers a patient-initiated source of questions. Sponsor support alone does not establish direction toward a drug, nor do disclaimers prove users can redirect the bot.
What can the patient understand, question, or do?
Condition education can prepare discussion, but actual response provenance, alternative explanations and correction behavior are not established from terms.
Can the patient evaluate the conditions of use?
The collaboration and sponsor are visible on the terms page. Privacy behavior and in-chat sponsor visibility remain unknown, with no automatic penalty.
Text findings
Conditions of use
Published controls and their limits
The collaboration and sponsor are visible on the terms page. Privacy behavior and in-chat sponsor visibility remain unknown, with no automatic penalty.
What remains unknown?
Not tested or not established
Answer sourcing, user redirection, retention and sponsor influence in conversation remain unverified
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Earlier review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Answer sourcing, user redirection, retention and sponsor influence in conversation remain unverified No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Earlier review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
Document-based draft · Low to moderate for identified deployment and terms (AI-assisted draft)